|
|
|
|
|
CUSIP No. 25272T104
|
|
13D
|
|
Page
2
of 7
|
|
|
|
|
|
|
|
1
|
|
Names of reporting persons
RMD Family Gift Trust UAD 09/10/11
|
2
|
|
Check the appropriate box if a
member of a group
(a)
x
(b)
¨
|
3
|
|
SEC use only
|
4
|
|
Source of funds
OO
|
5
|
|
Check box if disclosure of legal
proceedings is required pursuant to Items 2(d) or 2(e)
¨
|
6
|
|
Citizenship or place of
organization
Illinois
|
Number of
shares
beneficially
owned by
each
reporting
person
with
|
|
7
|
|
Sole voting power
5,550
|
|
8
|
|
Shared voting power
0
|
|
9
|
|
Sole dispositive power
5,550
|
|
10
|
|
Shared dispositive power
0
|
11
|
|
Aggregate amount beneficially owned by each reporting person
5,550
|
12
|
|
Check box if the aggregate amount
in Row (11) excludes certain shares
¨
|
13
|
|
Percent of class represented by
amount in Row (11)
0.007%
(1)
|
14
|
|
Type of reporting
person
OO
|
(1)
|
Based on 75,447,688 outstanding shares of common stock of the Issuer as of the date of this Schedule 13D.
|
|
|
|
|
|
CUSIP No. 25272T104
|
|
13D
|
|
Page
3
of 7
|
Item 1.
|
Security and Issuer
|
This
statement relates to the common stock, par value $0.01 per share (the Common Stock), of Diamond Resorts International, Inc. (the Issuer). The address of the principal executive offices of the Issuer is 10600 West Charleston
Boulevard, Las Vegas, Nevada 89135.
Item 2.
|
Identity and Background
|
This statement is being filed by RMD Family Gift Trust, an Illinois trust (the Reporting Person).
The principal business address of the Reporting Person is 900 North Michigan Avenue, Suite 1720, Chicago, IL 60611.
The Reporting Person is primarily engaged in the business of managing, controlling, caring for, protecting, preserving, administering,
investing and re-investing the trust estate of the Reporting Person according to the best judgment of the Trustee.
The
Reporting Person has not, during the past five years, (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any
violation with respect to such laws.
The Reporting Person is deemed to be a member of a group, as such term is
defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the Exchange Act), and Rule 13d-5 promulgated thereunder, as a result of being party to the Stockholders Agreement (as defined herein), as more fully
described in Items 4 and 5 hereof.
Item 3.
|
Source and Amount of Funds or Other Consideration.
|
On July 24, 2013, the Issuer closed the initial public offering (the IPO) of an aggregate of 17,825,000 shares of Common Stock at the IPO price of $14.00 per share. In the IPO, the
Issuer sold 16,100,000 shares of Common Stock, and Cloobeck Diamond Parent, LLC (CDP), in its capacity as a selling stockholder, sold 1,725,000 shares of Common Stock.
In connection with the closing of the IPO, on July 24, 2013, the Reporting Person purchased 5,550 shares of Common Stock in the IPO
pursuant to the directed share program established by the underwriters for the IPO, at a price per share of $14.
Item 4.
|
Purpose of Transaction.
|
The disclosure set forth in Item 3 of this Schedule 13D is incorporated herein by reference.
In connection with the closing of the IPO, the Reporting Person has entered into a Stockholders Agreement, dated as of
July 17, 2013 (the Stockholders Agreement), with other individuals and entities who are now stockholders of the Issuer. The Stockholders Agreement covers an aggregate of 40,119,261 shares of Common Stock, representing approximately
53.2% of the outstanding Common Stock. In addition, CDP and DRP Holdco, LLC (DRPH), which beneficially own an aggregate of approximately 22.0% and 15.0%, respectively, of the Common Stock, and are parties to the Stockholders Agreement,
entered into a Director Designation Agreement, dated as of July 17, 2013 (the Director Designation Agreement), with the Issuer.
|
|
|
|
|
CUSIP No. 25272T104
|
|
13D
|
|
Page
4
of 7
|
Pursuant to the Director Designation Agreement, (i) CDP has the right to designate up to two of the
Issuers directors, for so long as CDP and its affiliates, collectively, own at least ten percent (10%) of the issued and outstanding shares of Common Stock, and (ii) DRPH has the right to designate up to two of the Issuers
directors, for so long as DRPH and its affiliates, collectively, own at least ten percent (10%) of the issued and outstanding shares of Common Stock, provided that, in each case, if the board of directors of the Issuer (the Board)
determines in good faith, after consultation with outside legal counsel, that the nomination of any such designee would constitute a breach of its fiduciary duties to the Issuers stockholders, CDP or DRPH, as applicable, must designate another
individual (who will also be subject to the same determination by the Board).
Pursuant to the Stockholders Agreement, each of
the parties thereto has agreed to cause the shares of Common Stock held by such party to be voted, at any meeting of stockholders of the Issuer called for such purpose, for the individuals nominated by the Board for election to the Board (including
those nominees selected by CDP and DRPH pursuant to the Director Designation Agreement). Each of the parties to the Stockholders Agreement has agreed to appoint Stephen J. Cloobeck and David F. Palmer as their proxies and attorneys-in-fact to vote
their shares of Common Stock in the event that they fail to vote in accordance with the provisions of the Stockholders Agreement. In addition, in the event that any party to the Stockholders Agreement transfers any shares of Common Stock to an
affiliate, another party to the Stockholders Agreement or an affiliate of another party to the Stockholders Agreement, the transferee will be required to sign a joinder to the Stockholders Agreement.
As a result of the Stockholders Agreement, the parties thereto are deemed to constitute a group, for purposes of the Exchange
Act, that holds more than 50% of the Common Stock, and the Issuer will therefore qualify as a controlled company under the corporate governance rules of the New York Stock Exchange.
In connection with the closing of the IPO, (i) certain parties to the Stockholders Agreement (including the Reporting Person)
purchased shares of Common Stock in the IPO pursuant to the directed share program established by the underwriters for the IPO, (ii) each member of the Board who is not an officer or employee of the Issuer, or the Chairman or Vice Chairman of
the Board (each such individual, a Non-Officer Director) was granted shares of restricted common stock for service on the Board, pursuant to the Issuers 2013 Incentive Compensation Plan, and (iii) each Non-Officer Director
received shares of fully vested Common Stock in lieu of the cash retainer to which such Non-Officer Director was otherwise entitled, pursuant to the Non-Officer Director Share Accumulation Program adopted as part of the Issuers 2013 Incentive
Compensation Plan. Pursuant to the Non-Officer Director Share Accumulation Program, each Non-Officer Director is entitled to elect to utilize all or a portion of his annual retainer fee to acquire shares of Common Stock.
The transactions contemplated by the Stockholders Agreement and the Director Designation Agreement may result in certain actions
specified in Items 4(a) through (j) of Schedule 13D, including changes in the Board. Furthermore, as stockholders of the Issuer, on an ongoing basis, the Reporting Person will review the Issuers operating, management, business affairs,
capital needs and general industry and economic conditions, and, based on such review, the Reporting Person may, from time to time, determine to increase or decrease their ownership of Common Stock, vote to approve an extraordinary corporate
transaction with regard to the Issuer or engage in any of the events set forth in Items 4(a) through (j) of Schedule 13D. Except as otherwise provided herein, the Reporting Person currently has no intention of engaging in any of the events set
forth in Items 4(a) through (j) of Schedule 13D.
|
|
|
|
|
CUSIP No. 25272T104
|
|
13D
|
|
Page
5
of 7
|
The summaries contained herein of the Stockholders Agreement and the Director Designation Agreement do
not purport to be complete and are qualified in their entirety by reference to the full text of such documents, which are included as Exhibits 1 and 2, respectively, to this Schedule 13D and are incorporated herein by reference.
Item 5.
|
Interest in Securities of the Issuer.
|
(a) The Reporting Person may be deemed to beneficially own 5,550 shares of Common Stock, representing approximately 0.007% of the Issuers outstanding Common Stock (based on 75,447,688 shares of
Common Stock outstanding).
(b) The Reporting Person has sole voting power and sole dispositive power with regard to such
shares.
The share ownership reported for the Reporting Person does not include any shares of Common Stock owned by the other
parties to the Stockholders Agreement, except to the extent disclosed in this Schedule 13D. The Reporting Person is deemed to be a member of a group for purposes of the Exchange Act with the other parties to the Stockholders Agreement.
The Reporting Person disclaims beneficial ownership of any shares of Common Stock owned by the other parties to the Stockholders Agreement, except to the extent disclosed in this Schedule 13D.
(c) No transactions in the Common Stock have been effected by the Reporting Person within the past 60 days, except as disclosed under
Item 3 of this Schedule 13D, all of which disclosures are incorporated herein by reference.
(d) Not applicable.
(e) Not applicable.
Item 6.
|
Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
|
The responses set forth in Items 3 and 4 of this Schedule 13D are hereby incorporated by reference.
Each of the Issuers officers, directors and principal stockholders (including the Reporting Person) has executed a Lock-Up
Agreement (each, a Lock-Up Agreement and, collectively, the Lock-Up Agreements). Each of the Lock-Up Agreements provides that the party thereto will not offer, sell, contract to sell, pledge or otherwise dispose of, directly
or indirectly, any shares of Common Stock or securities convertible into or exchangeable or exercisable for any shares of Common Stock, enter into a transaction that would have the same effect, or enter into any swap, hedge or other arrangement that
transfers, in whole or in part, any of the economic consequences of ownership of Common Stock, or publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement,
without, in each case, the prior written consent of Credit Suisse Securities (USA) LLC, for a period of 180 days after July 18, 2013 (which 180-day period is subject to extension under certain specified conditions).
Descriptions and summaries of the Lock-Up Agreement set forth above in this Item 6 do not purport to be complete and are qualified
in their entirety by reference to the full text of such document, which is included as Exhibit 3 to this Schedule 13D and is incorporated herein by reference.
|
|
|
|
|
CUSIP No. 25272T104
|
|
13D
|
|
Page
6
of 7
|
Item 7.
|
Material to be Filed as Exhibits.
|
The following documents are filed as exhibits:
|
1.
|
Form of Stockholders Agreement (incorporated by reference to Exhibit 10.45 to Amendment No. 1 to the Registration Statement on Form S-1 filed by the Issuer on
July 9, 2013)
|
|
2.
|
Director Designation Agreement (incorporated by reference to Exhibit 10.44 to Amendment No. 1 to the Registration Statement on Form S-1 filed by the Issuer on
July 9, 2013)
|
|
3.
|
Form of Lock-Up Agreement (incorporated by reference to Exhibit B to Exhibit 1.1 to Amendment No. 1 to the Registration Statement on Form S-1 filed by the Issuer
on July 9, 2013)
|
|
4.
|
Power of Attorney for RMD Family Gift Trust (incorporated by reference to Exhibit A to the Form 3 filed by RMD Family Gift Trust on August 5, 2013)
|
|
|
|
|
|
CUSIP No. 25272T104
|
|
13D
|
|
Page
7
of 7
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: August 5, 2013
|
RMD FAMILY GIFT TRUST
|
|
/s/ Jared T. Finkelstein, as attorney-in-fact for RMD Family Gift Trust
|
Jared T. Finkelstein, attorney-in-fact for RMD Family Gift Trust
|